Schizophrenia Trial, Recruiting (NCT06728241)

Schizophrenia Trial, Recruiting NCT06728241 Sponsor: Oslo University Hospital Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT06728241 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 17 and 65 years of age
People who are currently receiving treatment for psychosis at one of the participating hospital clinics
People who have been diagnosed with a schizophrenia-related condition, or a mood disorder that includes psychotic symptoms, according to recognised diagnostic codes
People who report finding it difficult to go outside or take part in everyday activities
People who are willing and able to give written consent to take part in the study

Who may not be able to join:

People who have photosensitive epilepsy (seizures triggered by light)
People who have significant difficulties with vision, hearing, or balance
People who do not have a sufficient understanding of Norwegian
People who are currently receiving treatment in a forensic (secure) mental health setting or a Psychiatric Intensive Care Unit
People whose primary diagnosis is an alcohol or substance use disorder, a personality disorder, or an organic brain syndrome
People who have a clinically significant learning disability

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jan Ivar Røssberg, PhD, Universitetet i Oslo/Oslo universitetssykehus

Phone: +47 47876866

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06728241

Sponsor: Oslo University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: +47 47876866

More information: https://clinicaltrials.gov/study/NCT06728241

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 17 and 65 years of age
People who are currently receiving treatment for psychosis at one of the participating hospital clinics
People who have been diagnosed with a schizophrenia-related condition, or a mood disorder that includes psychotic symptoms, according to recognised diagnostic codes
People who report finding it difficult to go outside or take part in everyday activities
People who are willing and able to give written consent to take part in the study

Who may not be able to join:

People who have photosensitive epilepsy (seizures triggered by light)
People who have significant difficulties with vision, hearing, or balance
People who do not have a sufficient understanding of Norwegian
People who are currently receiving treatment in a forensic (secure) mental health setting or a Psychiatric Intensive Care Unit
People whose primary diagnosis is an alcohol or substance use disorder, a personality disorder, or an organic brain syndrome
People who have a clinically significant learning disability

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Oslo University Hospital

Registry

ClinicalTrials.gov

Start date

6 December 2024

Est. completion

31 December 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Oxford Cognitions and Defences Questionnaire (O-CDQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov